检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs.

Aliza Hussain,David Ramsey,Michelle Lee,Dhruv Mahtta,Muhammad Shahzeb Khan,Vijay Nambi,Christie M Ballantyne,Laura A Petersen, Adrienne D Walker,Waleed T Kayani,Javed Butler,Leandro Slipczuk,Joseph G Rogers,Biykem Bozkurt,Sankar D Navaneethan,Salim S Virani

JACC. Heart failure（2023）

引用 0|浏览55
暂无评分
摘要
Utilization rates of SGLT2 inhibitors are low in patients with ASCVD, HF, and T2DM, with high residual facility-level variation. These findings suggest opportunities to optimize SGLT2 inhibitor use to prevent future adverse cardiovascular events.
更多
查看译文
关键词
atherosclerotic cardiovascular disease,heart failure,SGLT2 inhibitors,type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要